Galimedix, Inc. | WebDisclosure

Basculer en Français

11280	Companies
250617	Keywords
179241	Articles
136432	Press releases

Home
Companies
Galimedix, Inc.

PRESS RELEASE

published on 03/08/2024 at 10:00, 2 years 7 months ago

Galimedix Therapeutics presents new scientific data showing promising neuroprotective effects of GAL-201 for the treatment of Alzheimer’s disease at AD/PD™ 2024
Galimedix Therapeutics presents new scientific data at AD/PD(TM) 2024, showing neuroprotective effects of GAL-201 for Alzheimer’s disease treatment, targeting misfolded Aβ monomers to prevent toxic aggregation

Alzheimer's Disease Galimedix Therapeutics Neuroprotective Effects Scientific Data AD/PD 2024
PRESS RELEASE

published on 02/28/2024 at 14:00, 2 years 8 months ago

Galimedix Therapeutics announces new pre-clinical data with GAL-201 in an Alzheimer's disease transgenic model to be presented at AD/PD™ 2024 Conference
Galimedix Therapeutics to present new pre-clinical data with GAL-201 in an Alzheimer's disease transgenic model at AD/PD™ 2024 Conference, showing promise in targeting amyloid beta oligomers and protofibrils

Alzheimer's Disease GAL-201 Galimedix Therapeutics Pre-clinical Data AD/PD™ 2024 Conference
BRIEF

published on 02/28/2024 at 14:00, 2 years 8 months ago

Galimedix Therapeutics Presents New Preclinical Data on GAL-201 at AD/PD™ 2024 Conference

Alzheimer's Disease GAL-201 AD/PD™ 2024 Galimedix Therapeutics Preclinical
BRIEF

published on 02/28/2024 at 14:00, 2 years 8 months ago

Galimedix Therapeutics présente de nouvelles données précliniques sur le GAL-201 lors de la conférence AD/PD™ 2024

GAL-201 Maladie D'Alzheimer Préclinique AD/PD™ 2024 Galimedix Therapeutics
PRESS RELEASE

published on 10/25/2023 at 14:00, 3 years ago

Galimedix Appoints Dr. Luciana Summo as Vice President, R&D Operations

Accesswire

Published on 11/04/2026 at 23:10, 7 hours 51 minutes ago

Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 8 hours 1 minute ago

Avino Reports Q3 2026 Financial Results
Published on 11/04/2026 at 23:00, 8 hours 1 minute ago

Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 8 hours 46 minutes ago

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 8 hours 56 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/05/2026 at 06:58, 3 minutes ago

Aareal Bank leverages its operational strength to set the course for its strategic future
Published on 11/05/2026 at 06:58, 3 minutes ago

AT&S reports record second-quarter results and fully confirms full-year guidance
Published on 11/05/2026 at 06:30, 31 minutes ago

HENSOLDT increases adjusted EBITDA by 33% and refines guidance for 2026 upwards
Published on 11/05/2026 at 06:30, 31 minutes ago

Formycon invites to conference call on 2026 nine-month results and announces participation in international investor conferences
Published on 11/05/2026 at 06:20, 41 minutes ago

Zhejiang Showcases Its Cultural and Tourism Appeal in Hamburg at "Come for the Stories" Event

Les Echos

Published on 11/04/2026 at 18:00, 13 hours 1 minute ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 13 hours 1 minute ago

L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:45, 13 hours 16 minutes ago

October 2026
Published on 11/04/2026 at 17:45, 13 hours 16 minutes ago

Octobre 2026
Published on 11/04/2026 at 17:44, 13 hours 17 minutes ago

Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE